Adaptimmune Therapeutics Plc ADR (ADAPY)

$0.05 0.00 (-1.82%)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 45,989,301
Avg Vol 115,232,406
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 15%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Adaptimmune Therapeutics plc engages in research, development, and subsequent manufacture and commercialisation of cell therapies to treat cancer in the United States and the United Kingdom. The company was founded in 2008 and is headquartered in Abingdon, the United Kingdom.

Industry: Biotechnology
Sector: Healthcare
Address:
The Innovation Centre, 99 Park Drive, Milton Park, Abingdon, United Kingdom
US_Bull
US_Bull Aug. 19 at 1:57 PM
$ADAPY Again SP artificially suppressed stock should be up +40% easily in light of today's news they are not letting her rise on the OTC remember on the Expert Market on a day like today it would easily fly. Also our imaginary market cap is a big joke which is by no means a true representation of the true value of the company. I am feeling more and more confident we are gonna cash out soon.
0 · Reply
US_Bull
US_Bull Aug. 19 at 1:46 PM
$ADAPY With tpday's news there is abs. no reason to even open up at red part of the reason why microcaps have been struggling is due to year long yields, which make borrowing costs much more expensive. With yields falling now I see that at least as strong as a company specific catalyst as macroeconomics move the overall market, sectors and us.
1 · Reply
Hodl707
Hodl707 Aug. 19 at 1:32 PM
$ADAPY opened on the green side I was thinking we were going to open at .022!!
0 · Reply
US_Bull
US_Bull Aug. 19 at 1:18 PM
$ADAPY Look for volume today I expect intense buying today in light of yields pulling back aggressively! I could see this as the starting catalyst towards our climb to 0.1$+
0 · Reply
US_Bull
US_Bull Aug. 19 at 1:11 PM
$ADAPY "Treasury yields pulled back on Wednesday from multi-year highs seen earlier this week, with the long end of the curve dropping sharply after the Treasury Department announced an upscaled buyback operation of U.S. long-term debt. The 30-year Treasury bond yield shed nearly 9 basis points to 5.196%. The 10-year U.S. Treasury note yield lost 6 basis points to trade at 4.647%. The 30-year earlier this week hit a high of above 5.33%." Rising yields are bad for equities especially for the entire biosector maybe just maybe this is the 180 bullish turn for the sector after years of inflation!!!
0 · Reply
US_Bull
US_Bull Aug. 19 at 1:09 PM
$ADAPY Boo yeah double bullish perfect storm MRK and MRNA vaccine news exploding the bio market and Yields pull back from multi-year highs after Treasury Department says it will double government debt repurchase size. I think we will go up extensively today! The treasury buying is extremely bullihs for the overall market.
1 · Reply
US_Bull
US_Bull Aug. 19 at 11:16 AM
$ADAPY Will never ever happen Board of Directors would never be allowed to unload the company for 4 cents especially since they have PR'ed multiple times about maximizing SH value. Even last resort including a private equity taking over the company likely talking about ~0.15-0.20$/ADR. I am gonna try and buy more today as well as I have transferred more funds.
2 · Reply
PaidPiper
PaidPiper Aug. 19 at 11:00 AM
$ADAPY but fair value ≠ strategic value. That's the play here..
0 · Reply
PaidPiper
PaidPiper Aug. 19 at 10:39 AM
$ADAPY 25.95mil cash and cash equivalants as of December 2025. USWM transaction generated 50.24mil, they repaid 50.94mil to Hercules. Then PRAME sold 7mil upfront. Current cash on hand ~ 32mil - 1 year of the lowered burn rate (12x~500k=6mil). Cash on hand is maybe 25mil right now or .095/ADR
0 · Reply
manny11419
manny11419 Aug. 19 at 10:30 AM
$ADAPY Got my 100k yesterday...will try today for another 100k. I figure worse case USMW take it all for .04.
0 · Reply
Latest News on ADAPY
No data available.
US_Bull
US_Bull Aug. 19 at 1:57 PM
$ADAPY Again SP artificially suppressed stock should be up +40% easily in light of today's news they are not letting her rise on the OTC remember on the Expert Market on a day like today it would easily fly. Also our imaginary market cap is a big joke which is by no means a true representation of the true value of the company. I am feeling more and more confident we are gonna cash out soon.
0 · Reply
US_Bull
US_Bull Aug. 19 at 1:46 PM
$ADAPY With tpday's news there is abs. no reason to even open up at red part of the reason why microcaps have been struggling is due to year long yields, which make borrowing costs much more expensive. With yields falling now I see that at least as strong as a company specific catalyst as macroeconomics move the overall market, sectors and us.
1 · Reply
Hodl707
Hodl707 Aug. 19 at 1:32 PM
$ADAPY opened on the green side I was thinking we were going to open at .022!!
0 · Reply
US_Bull
US_Bull Aug. 19 at 1:18 PM
$ADAPY Look for volume today I expect intense buying today in light of yields pulling back aggressively! I could see this as the starting catalyst towards our climb to 0.1$+
0 · Reply
US_Bull
US_Bull Aug. 19 at 1:11 PM
$ADAPY "Treasury yields pulled back on Wednesday from multi-year highs seen earlier this week, with the long end of the curve dropping sharply after the Treasury Department announced an upscaled buyback operation of U.S. long-term debt. The 30-year Treasury bond yield shed nearly 9 basis points to 5.196%. The 10-year U.S. Treasury note yield lost 6 basis points to trade at 4.647%. The 30-year earlier this week hit a high of above 5.33%." Rising yields are bad for equities especially for the entire biosector maybe just maybe this is the 180 bullish turn for the sector after years of inflation!!!
0 · Reply
US_Bull
US_Bull Aug. 19 at 1:09 PM
$ADAPY Boo yeah double bullish perfect storm MRK and MRNA vaccine news exploding the bio market and Yields pull back from multi-year highs after Treasury Department says it will double government debt repurchase size. I think we will go up extensively today! The treasury buying is extremely bullihs for the overall market.
1 · Reply
US_Bull
US_Bull Aug. 19 at 11:16 AM
$ADAPY Will never ever happen Board of Directors would never be allowed to unload the company for 4 cents especially since they have PR'ed multiple times about maximizing SH value. Even last resort including a private equity taking over the company likely talking about ~0.15-0.20$/ADR. I am gonna try and buy more today as well as I have transferred more funds.
2 · Reply
PaidPiper
PaidPiper Aug. 19 at 11:00 AM
$ADAPY but fair value ≠ strategic value. That's the play here..
0 · Reply
PaidPiper
PaidPiper Aug. 19 at 10:39 AM
$ADAPY 25.95mil cash and cash equivalants as of December 2025. USWM transaction generated 50.24mil, they repaid 50.94mil to Hercules. Then PRAME sold 7mil upfront. Current cash on hand ~ 32mil - 1 year of the lowered burn rate (12x~500k=6mil). Cash on hand is maybe 25mil right now or .095/ADR
0 · Reply
manny11419
manny11419 Aug. 19 at 10:30 AM
$ADAPY Got my 100k yesterday...will try today for another 100k. I figure worse case USMW take it all for .04.
0 · Reply
PaidPiper
PaidPiper Aug. 19 at 7:50 AM
$ADAPY @duepillagence also keep in mind it's a 'TSA' of 1 preclinical program. There are no ongoing patients, clinical sites, obligations, sponsorships, commercial inventory, or commercial manufacturing network to transition. Should be wrapped up pretty quick, it's been 5 months since that sale so I'm assuming this is done or near done already
2 · Reply
Nnanok
Nnanok Aug. 19 at 6:45 AM
$ADAPY A lot of NCCN institutions involved in these trials is always a good thing to see. On the flip side is this funky little trial in Denmark utilizing genetically modified TILs in melanoma (yes, like IOVA). "The lentiviral vector used to integrate the IL-7 gene to the TILs is manufactured and provided by the British/American biotechnological company, Adaptimmune. The genetically modified TILs are therefore called ADP-TILIL7." For now, not much to really hang a hat on, but this trial was inspired by a previous PH3 that showed encouraging results. https://clinicaltrials.gov/study/NCT06204991?term=adaptimmune&viewType=Card&page=2&rank=14
0 · Reply
PaidPiper
PaidPiper Aug. 19 at 6:33 AM
$ADAPY @duepillagence last 5 words. My interpretation is that "expected to recieve" is not the same as a hard deadline.
0 · Reply
Hodl707
Hodl707 Aug. 19 at 6:01 AM
$ADAPY The Final Countdown to December 31, 2026The chess board is now entirely clear.The US WorldMeds deal cleared Adaptimmune's debts and took away the expensive overhead.The June 16 Trial Completion perfectly packaged the liver cancer asset.The PRAME TSP is completing the transfer of the core biological blueprint.When CEO/CFO Chris Hill's contract officially expires on December 31, 2026, the secret buyer will trigger their master option. The final $5 million milestone will release, and the Big Pharma giant will step out from behind the curtain to announce they have bought the remaining shell—instantly absorbing the Allogeneic platform, the CD70 program, and the clinically successful AFP liver cancer weapon in one single, massive corporate headline.
0 · Reply
Hodl707
Hodl707 Aug. 19 at 4:27 AM
$ADAPY part 2 ) .The Strategy: The companies sign an ongoing TSA. Under this agreement, the target company transfers their technical process to the buyer's labs under the guise of a "service evaluation."The Outcome: The buyer gets to verify the technology works. If it does, they proceed with the merger. If it fails, they can quietly walk away by terminating the TSA, and no one ever knows a merger was even on the table.3. Setting Up the Pipeline EarlyIf a merger is a done deal but just waiting on final legal or regulatory sign-off, the companies don't want to waste 6 to 12 months sitting on their hands.The Strategy: They use the open-ended TSA to start the incredibly slow process of transferring data, validating equipment, and training staff right now.The Transition: The moment the merger is legally finalized, the TSA is instantly dissolved because the two companies are now one single entity. The "ongoing relationship" was just a placeholder until ownership officially transferred.
1 · Reply
Hodl707
Hodl707 Aug. 19 at 4:26 AM
$ADAPY . Part 1 The Perfect Cover Story (Gun-Jumping Protection)Under UK competition law (governed by the Competition and Markets Authority), two companies are legally forbidden from acting as a single merged entity before the deal is officially cleared and closed. Doing so is called "gun-jumping" and carries massive fines.The Strategy: By framing their pre-merger collaboration as a simple, routine "Technical Service Process," the companies can legally share technical data, run joint testing, and align their laboratory workflows.The Cover: To the outside world, regulators, and competitors, it just looks like a standard B2B vendor relationship. It hides the fact that a massive buyout or merger is being negotiated in the background.2. A Pre-Merger "Test Drive"Biotech mergers are incredibly risky. One company might claim their cell line or software platform works perfectly, but the buying company needs to see it with their own eyes before signing a multi-million-pound merger deal
0 · Reply
duepillagence
duepillagence Aug. 19 at 3:09 AM
$ADAPY In the PRAME "divestment" disclosing a TSA while void of an expiration date 100% suggests an "on-going" relationship.. Just fyi gang 🤔
1 · Reply
duepillagence
duepillagence Aug. 19 at 2:52 AM
$ADAPY Recall that we had a discussion concerning the PRAME "divestment" and the issue that a TSA may/may not have been disclosed? I think you mentioned that there was one (but it came with no expiration date, where did you see it?
0 · Reply
PaidPiper
PaidPiper Aug. 18 at 8:58 PM
$ADAPY too bad we closed below support. We've been avoiding that for months. Probably headed lower until news but that's just a hunch
1 · Reply
BK217
BK217 Aug. 18 at 7:45 PM
$ADAPY GUYS. IF YOU ONLY READ US BULLS POSTS YOUD THINK THIS WAS THE HOTTEST STOK IN ALL OF WALL STREET
0 · Reply
NexDollar
NexDollar Aug. 18 at 7:40 PM
$ADAPY not today, another day.
0 · Reply
Pimpdaddiaddi
Pimpdaddiaddi Aug. 18 at 1:42 PM
$ADAPY slow slow slow…nothing nothing nothing…can we get something to take us to a new level here?
1 · Reply